Home/Pipeline/TearScan IgE

TearScan IgE

Allergic Conjunctivitis

CommercialFDA 510(k) Cleared

Key Facts

Indication

Allergic Conjunctivitis

Phase

Commercial

Status

FDA 510(k) Cleared

Company

Axim Biotech

About Axim Biotech

AXIM Biotechnologies is a diagnostic-focused R&D company with a mission to improve patient lives through rapid, in-clinic testing solutions. The company has achieved commercial validation with two FDA-cleared ophthalmological diagnostics and is leveraging its integrated platform to diversify into early cancer detection and cannabinoid research. Its strategy combines direct commercialization, strategic alliances, and a client-focused diagnostic development service to address unmet needs in multiple therapeutic areas.

View full company profile

Therapeutic Areas

Ophthalmology Oncology Cannabinoids

Other Allergic Conjunctivitis Drugs

Drug	Company	Phase	Status
SEI-117	Santen Pharmaceutical	Phase 3	Active
Reproxalap	Aldeyra Therapeutics	Phase 3	Active